Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00987220 · ClinicalTrials.gov registry record
Effect of Aricept on Biomarkers (Acetylcholine, sAPP Alpha) In Cerebrospinal Fluid
A clinical trial, sponsored by Pfizer.
- Completed
- Registry status
- 12
- Enrollment target
NCT00987220 is a clinical trial that has completed, run by Pfizer. The registered enrollment target is 12 participants.
The verdict
NCT00987220 has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
It is hypothesized that the acetylcholinesterase inhibitor, donepezil, will increase acute cerebrospinal fluid (CSF) actylcholine levels in healthy volunteers following a 5mg single dose oral administration.
Interventions
- DRUG Placebo
- DRUG donepezil (Aricept)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2009-10 |
| Est. Completion | 2010-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00987220
The ClinicalTrials.gov registry entry for NCT00987220 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00987220 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00987220 about?
NCT00987220 is a clinical study titled "Effect of Aricept on Biomarkers (Acetylcholine, sAPP Alpha) In Cerebrospinal Fluid". It is hypothesized that the acetylcholinesterase inhibitor, donepezil, will increase acute cerebrospinal fluid (CSF) actylcholine levels in healthy volunteers following a 5mg single dose oral administration.
What is the current status of trial NCT00987220?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2009-10. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00987220?
The interventions under investigation include: Placebo (DRUG), donepezil (Aricept) (DRUG).
Who is sponsoring clinical trial NCT00987220?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.